Why Register?

By registering on our site you have unlocked a world of great content. We hope you enjoy it and find it useful.

Germany Suspends 80 Generic Drugs Over Poor Bioequivalence Trials

Drug Industry Daily
German regulators have published a list of 80 generic medicines whose approvals were yanked after EU authorities expressed concerns with contract research organization GVK Biosciences.

To View This Article:


Subscribe To Drug Industry Daily